AstraZeneca | Omløpsmidler



Current Assets Endring Dato
AbbVie USD 25.58B 2.2B 2024-12
Alcon AG USD 6.31B 10M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Fresenius EUR 11.45B 219M 2024-12
Fresenius Medical Care EUR 7.92B 168.26M 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Haleon 5.72B 1.01B 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Indivior 799M 65M 2024-09
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.93B 882M 2024-09
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Orion EUR 1.02B 40.7M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Philips EUR 10.02B 116M 2024-12
Recordati EUR 1.26B 10.61M 2024-09
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
UCB EUR 4.79B 1.47B 2024-12



AstraZeneca Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.